BSE filing, NSE: NORRIS. Summary written from the filing by ALFA Finder's alert engine.
Norris Medicines Ltd: key numbers
- Share price
- ₹14.62
- Market cap
- ₹14.62 Cr
- Revenue (annual)
- ₹8.13 Cr
- Net profit (annual)
- ₹-0.28 Cr
- P/E (TTM)
- -39.8×Sector 46.1×
- Promoter holding
- 34.01%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Norris Medicines Ltd
All →Norris Medicines Other Announcement
Norris Medicines Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Norris Medicines Annual General Meeting
Norris Medicines Limited held its 35th Annual General Meeting on September 29, 2026, where members transacted various ordinary and special business items.
Norris Medicines Annual Report
Norris Medicines Limited has filed its 35th Annual Report for the financial year 2025-26, including the notice of its upcoming Annual General Meeting.
Norris Medicines Annual General Meeting
Norris Medicines approved the Directors' Report, Annual Report, and convening of the 35th Annual General Meeting for September 29, 2026.
Norris Medicines Q1 FY27 Results: Net Loss of ₹0.4 Cr, Loss Widens
Norris Medicines Ltd reported revenue from operations of ₹0.9 Cr (-40.0% YoY) and a net loss of ₹0.4 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.4 Cr
Norris Medicines Board Meeting Date
Norris Medicines Limited has scheduled a board meeting for August 14, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.
Other management change announcements
All →Hexaware Technologies Management Change
Hexaware appointed Arjun Shah and Gregory Zeluck as Non-Executive Directors from 28 October 2026. Directors Neeraj Bharadwaj and Julius Genachowski resigned, and Girish Pai's resignation is effective 13 November 2026.
GMR Airports Management Change
GMR Airports appointed Sanjeev Gupta as Executive Director (Deputy CEO) effective 29 October 2026. Non-Executive Director Alexis Riols resigned effective 28 October 2026.
Raymond Realty Management Change
Raymond Realty said joint statutory auditor Chaturvedi & Shah LLP resigned on 28 October 2026 after a dispute over audit fee revision. Walker Chandiok & Co LLP continues as the other statutory auditor.
Aarti Pharmalabs Management Change
Aarti Pharmalabs accepted CFO Piyush Lakhani's resignation, effective 30 October 2026, and appointed Vibha Thakker as CFO from 31 October 2026. The filing records a senior management change with no monetary amount.
TruCap Finance Management Change
TruCap Finance designated three employees as Senior Management Personnel, effective 29 October 2026. The changes are additional charges for Product, Operations and Contact Centre roles.
Sayaji Hotels (Indore) Management Change
Sayaji Hotels (Indore) appointed Azhar Yusuf Dhanani as Additional Non-Executive Non-Independent Director effective October 28, 2026. Shareholder approval is required within three months.